Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
493.4 INR | +0.41% | -4.85% | +49.35% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.35% | 512M | |
+36.67% | 723B | |
+31.03% | 598B | |
-3.21% | 364B | |
+20.09% | 331B | |
+4.09% | 288B | |
+16.04% | 244B | |
+9.76% | 210B | |
-5.03% | 208B | |
+9.05% | 169B |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- Shilpa Medicare Gets US FDA Nod for Apremilast Tablets